3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
2
von Hippel-Lindau Disease
1
Triple Negative Breast Neoplasms
1
Sarcoma, Kaposi
1
Sarcoma
1
Neoplasm Metastasis
1
Metastatic Digestive System Neuroendocrine Tumor G1
1
Meningioma
1
Liposarcoma
1
Leiomyosarcoma
1
Hamartoma Syndrome, Multiple
1
Glioma
1
Glioblastoma
1
Endometrial Neoplasms
1
Diffuse Intrinsic Pontine Glioma
1
Carcinoma, Renal Cell
1
Brain Neoplasms
1
Bone Neoplasms
1
Autistic Disorder
1
Astrocytoma
1
Interventions
Oxaliplatin
9
Leucovorin
8
Fluorouracil
8
Bevacizumab
6
Cetuximab
5
Specimen Handling
4
fludarabine
3
Pemetrexed
3
Nivolumab
3
Magnetic Resonance Spectroscopy
3
Cyclophosphamide
3
pembrolizumab
2
encorafenib
2
dehydroftorafur
2
aldesleukin
2
Irinotecan
2
Immunoglobulin G
2
Gemcitabine
2
Folfox protocol
2
Disulfides
2
Cisplatin
2
Celecoxib
2
Carboplatin
2
ulixertinib
1
trastuzumab biosimilar HLX02
1
trametinib
1
temsirolimus
1
sapanisertib
1
repotrectinib
1
relatlimab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Colonic Neoplasms
×
Everolimus
×
30 days
×
Clear all
No trials found.